Myocines produced by active muscles like oncostatin M, irisin, and SPARC can directly downregulate cancer growth by impacting cell proliferation, stemness, apoptosis, drug resistance, metabolic remodeling, and the epithelial–mesenchymal tissue transformation of cancer cells [34]. This evidence concerns the gene SPARC and cancer.